RHEUMATOLOGY / LETTER TO THE EDITOR
 
TOPICS
 
REFERENCES (19)
1.
Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Le syndrome acné pustulose hyperostose ostéite (SAPHO). Résultats d’une enquête nationale. 85 observations [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic 1987; 54: 187-96.
 
2.
Sun Y, Li C, Lu Q, et al. Integrative analysis of lncRNA-mRNA profile reveals potential predictors for SAPHO syndrome. Front Genet 2021; 12: 684520.
 
3.
Przepiera-Będzak H, Fischer K, Brzosko M. Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome. Arch Med Sci 2018; 17: 120-6.
 
4.
Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P. Adult-onset Still’s disease. Autoimmun Rev 2014; 13: 708-22.
 
5.
Wang R, Li Y, Liu Y, Hou X, Li C. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with henoch-schönlein purpura: a case report. Clin Cosmet Investig Dermatol 2023; 16: 1089-94.
 
6.
Huang Z, Lee PY, Yao X, Zheng S, Li T. Tofacitinib treatment of refractory systemic juvenile idiopathic arthritis. Pediatrics 2019; 143: e20182845.
 
7.
Li C, Li Z, Cao Y, et al. Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. JAMA Dermatol 2021; 157: 74-8.
 
8.
Jung JY, Choi B, Sayeed HM, et al. Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still’s disease. Int J Immunopathol Pharmacol 2018; 32: 2058738418791284.
 
9.
Li Z, Liu HL, Chen J, et al. Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still’s disease in Chinese individuals. Ann Rheum Dis 2020; 79: 161-3.
 
10.
Przepiera-Będzak H, Brzosko M. SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Adv Dermatol Allergol 2021; 38: 937-42.
 
11.
Carneiro S, Sampaio-Barros PD. SAPHO syndrome. Rheum Dis Clin North Am 2013; 39: 401-18.
 
12.
Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum 2012; 42: 254-65.
 
13.
Ono R, Iwahana T, Toriumi S, et al. Fulminant myocarditis with adult-onset Still’s disease: case-based review. Clin Rheumatol 2023; 42: 2507-14.
 
14.
Zhang S, Li C, Zhang S, et al. Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Mod Rheumatol 2019; 29: 523-30.
 
15.
Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20912865.
 
16.
Murdaca G, Colombo BM, Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 2011; 6: 487-95.
 
17.
Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW. Potential role of Th17 cells in the pathogenesis of adult-onset Still’s disease. Rheumatology 2010; 49: 2305-12.
 
18.
Firinu D, Barca MP, Lorrai MM, et al. TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome. Autoimmunity 2014; 47: 389-94.
 
19.
Mitrovic S, Hassold N, Kamissoko A, et al. Adult-onset Still’s disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift? Rheumatology (Oxford) 2022; 61: 2535-47.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top